Want to join the conversation?
$CELG said it has settled REVLIMID (lenalidomide) patent litigation with Natco Pharma of India. Under the deal, Natco to acquire license to sell generic lenalidomide in US without volume limitation beginning in Jan. 2026 & volume-limited entry beginning in March 2022 with anticipated mid-single-digit percentage of capsules sold in first 12 months.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.